Clinical Trial Update: Cardiac Resynchronization Therapy Defibrillator Based Impedance Monitoring Study [NA]

View source ↗

Summary

This entry reports the completion of Abbott Medical Devices' Cardiac Resynchronization Therapy Defibrillator–based impedance monitoring study (NCT00500838) for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Cardiac Resynchronization Therapy Defibrillator with impedance monitoring

Snippet

Sponsor: Abbott Medical Devices | Conditions: Heart Failure | NA | Status: COMPLETED